Abstract
Biochemical changes accompanying the clinical cycle in periodic catatonia have been studied in this laboratory since 1927. Gjessing first suggested that cyclic variation in thyroid function might be involved in the clinical symptomatology of the illness. Clinical observations of a stuporous patient revealed many signs of adrenal activation. The symptoms during the switch from interval to psychotic phase were similar to those seen after an epinephrine injection. Further extensive studies of phenolic amines and phenolic acids have confirmed the overactivity of the sympathetic nervous system present during the catatonic phase in these cases.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Armstrong, M. D., Shaw, K. N. F. and Wall, P. E. (1956): The phenolic acids in human urine. J. biol. Chem.218, 293–303.
Bunney, W. E. Jr., Murphy, D. L., Goodwin, F. K. and Borge, G. (1970): The switch process from depression to mania: relationship to drugs which alter brain amines. Lancet1, 1022–1027.
Carlsson, A., Rasmussen, E. B. and Kristjansen, P. (1959): The urinary excretion of adrenaline and noradrenaline by schizophrenic patients during reserpine treatment. J. Neurochem.4, 318–320.
Gjessing, L. R. (1932): Beiträge zur Kenntnis der Pathophysiologie des katatonen Stupors: I. Mitteilung. Über periodisch rezidivierenden katatonen Stupor, mit kritischem Beginn und Abschluss. Arch. Psychiat. Nervenkr.96, 319–392.
Gjessing, L. R. (1935): Beiträge zur Kenntnis der Pathophysiologie der katatonen Erregung: III. Mitteilung. Über periodisch rezidivierende katatone Erregung, mit kritischem Beginn und Abschluss. Arch. Psychiat. Nervenkr.104, 355–416.
Gjessing, L. R. (1953): Beiträge zur Somatologie der periodischen Katatonie: VIII. Mitteilung. Wertung der Befunde II. Arch. Psychiat. Nervenkr.191, 297–326.
Gjessing, L. R. (1964a): Studies of periodic catatonia: I. Blood levels of protein-bound iodine and urinary excretion of vanillylmandelic acid in relation to clinical course. J. psychiat. Res.2, 123–134.
Gjessing, L. R. (1964b): Studies of periodic catatonia: II. The urinary excretion of phenolic amines and acids with and without loads of different drugs. J. psychiat. Res.2, 149–162.
Gjessing, L. R. (1965): Studies on urinary phenolic compounds in man. II. Phenolic acids and amines during a load of α-methyldopa and Disulfiram in periodic catatonia. Scand. J. clin. Lab. Invest.17, 549–557.
Gjessing, L. R. (1967a): Lithium citrate loading of a patient with periodic catatonia. Acta psychiat. scand.43, 372–375.
Gjessing, L. R. (1967b): Effect of thyroxine, pyridoxine, orphenadrine-HCl, reserpine and Disulfiram in periodic catatonia. Acta psychiat. scand.43, 376–384.
Greenspan, K., Schildkraut, J. J., Gorden, E. K., Baer, L., Aronoff, M. S. and Durell, J. (1970): Catecholamine metabolism in affective disorders — III. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J. psychiat. Res.7, 171–183.
Hatotani, N., Ishida, C., Yum, R., Maeda, M., Kato, Y., Nomura, Y., Wakao, T., Takekoshi, A., Yoshimoto, S., Yoshimoto, K. and Hiramoto, K. (1962): Psychophysiological studies of atypical psychosis — endocrinological aspect of periodic psychoses. Folia psychiat. neurol. jap.16, 248–292.
Kakimoto, Y. and Armstrong, M. D. (1962): The phenolic amines of human urine. J. biol. Chem.237, 208–214.
Paul, M. I., Cramer, H. and Bunney, W. E., Jr. (1971): Urinary adenosine 3’,5’-monophosphate in the switch process from depression to mania. Science171, 300–303.
Pllin, W. and Goldin, S. (1961): The physiological and psychological effects of intravenously administered epinephrine and its metabolism in normal and schizophrenic men— II. Psychiatric observations. J. psychiat. Bes.1, 50–67.
Pscheidt, G. R., Berlet, H. H., Bull, C., Spaide, J. and Himwich, H. E. (1964): Excretion of catecholamines and exacerbation of symptoms in schizophrenic patients. J. psychiat. Res.2, 163–168.
Schildkraut, J. J., Klerman, G. L., Hammond, R. and Friend, D. G. (1964): Excretion of 3-methoxy-4-hydroxy-mandelic acid (VMA) in depressed patients treated with antidepressant drugs. J. psychiat. Res.2, 257–266.
Takahashi, S. and Gjessing, L. R. (1972): Fluorometric method combined with thin-layer chromatography for the determination of epinephrine, norepinephrine and dopamine in human urine. (In preparation).
Takahashi, S. and Gjessing, L. R.: Studies of periodic catatonia—IV. Longitudinal study of catecholamine metabolism, with and without drugs. J. psychiat. Res. (In press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Akadémiai Kiadó, Budapest, Hungary
About this chapter
Cite this chapter
Takahashi, S., Gjessing, L.R. (1973). Longitudinal Study of Catecholamine Metabolism in Periodic Catatonia. In: Lissák, K. (eds) Hormones and Brain Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2007-4_50
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2007-4_50
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2009-8
Online ISBN: 978-1-4684-2007-4
eBook Packages: Springer Book Archive